Neurent Medical raised €62.5M in a Series C round announced on February 13, 2026. the company behind NEUROMARK, a minimally invasive solution to treat chronic rhinitis.
the company behind NEUROMARK, a minimally invasive solution to treat chronic rhinitis.
Neurent Medical, based in Galway, Ireland, announced €62.5M in Series C financing on February 13, 2026.
Participants include EQT Life Sciences, MVM Partners, Fountain Healthcare Partners, Atlantic Bridge, Sofinnova Partners, Enterprise Ireland.
Wayve uses end-to-end deep learning to develop artificial intelligence capable of complex driving.
ElevenLabs is an AI research and deployment company that develops platforms for generating speech, sound effects, music, and conversational voice agents.